Lifevantage EBITDA Margin 2010-2025 | LFVN

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Lifevantage (LFVN) over the last 10 years. The current EBITDA margin for Lifevantage as of March 31, 2025 is .
Lifevantage EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $0.22B $0.02B 7.21%
2024-12-31 $0.21B $0.01B 6.60%
2024-09-30 $0.20B $0.01B 5.10%
2024-06-30 $0.20B $0.01B 4.50%
2024-03-31 $0.21B $0.01B 4.39%
2023-12-31 $0.21B $0.01B 3.79%
2023-09-30 $0.21B $0.01B 3.76%
2023-06-30 $0.21B $0.01B 3.74%
2023-03-31 $0.21B $0.01B 2.37%
2022-12-31 $0.21B $0.01B 2.90%
2022-09-30 $0.21B $0.01B 3.41%
2022-06-30 $0.21B $0.01B 5.34%
2022-03-31 $0.21B $0.02B 8.57%
2021-12-31 $0.21B $0.02B 8.49%
2021-09-30 $0.22B $0.02B 10.96%
2021-06-30 $0.22B $0.02B 10.86%
2021-03-31 $0.23B $0.02B 10.67%
2020-12-31 $0.23B $0.03B 10.92%
2020-09-30 $0.23B $0.02B 9.96%
2020-06-30 $0.23B $0.02B 9.05%
2020-03-31 $0.23B $0.02B 8.30%
2019-12-31 $0.23B $0.02B 7.86%
2019-09-30 $0.23B $0.01B 6.19%
2019-06-30 $0.23B $0.01B 5.31%
2019-03-31 $0.22B $0.01B 4.91%
2018-12-31 $0.22B $0.01B 5.02%
2018-09-30 $0.21B $0.01B 6.19%
2018-06-30 $0.20B $0.01B 6.40%
2018-03-31 $0.20B $0.01B 5.00%
2017-12-31 $0.19B $0.01B 4.12%
2017-09-30 $0.19B $0.01B 3.09%
2017-06-30 $0.20B $0.01B 3.00%
2017-03-31 $0.20B $0.01B 4.46%
2016-12-31 $0.21B $0.01B 5.63%
2016-09-30 $0.22B $0.02B 6.94%
2016-06-30 $0.21B $0.02B 7.77%
2016-03-31 $0.20B $0.01B 6.57%
2015-12-31 $0.19B $0.01B 5.88%
2015-09-30 $0.18B $0.01B 6.01%
2015-06-30 $0.19B $0.02B 8.42%
2015-03-31 $0.20B $0.02B 9.45%
2014-12-31 $0.21B $0.02B 10.43%
2014-09-30 $0.22B $0.02B 11.16%
2014-06-30 $0.21B $0.02B 10.28%
2014-03-31 $0.21B $0.02B 8.57%
2013-12-31 $0.21B $0.02B 8.29%
2013-09-30 $0.21B $0.01B 5.83%
2013-06-30 $0.21B $0.01B 6.25%
2013-03-31 $0.20B $0.02B 9.95%
2012-12-31 $0.19B $0.02B 12.30%
2012-09-30 $0.16B $0.03B 16.35%
2012-06-30 $0.13B $0.02B 18.25%
2012-03-31 $0.10B $0.02B 17.71%
2011-12-31 $0.07B $0.01B 12.86%
2011-09-30 $0.05B $0.01B 13.46%
2011-06-30 $0.04B $0.00B 7.89%
2011-03-31 $0.03B 0 0.00%
2010-12-31 $0.02B 0 0.00%
2010-09-30 $0.02B $0.00B -26.67%
2010-06-30 $0.01B $-0.01B -63.64%
2010-03-31 $0.01B $-0.01B -122.22%
2009-12-31 $0.01B $-0.01B -171.43%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.160B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.188B 21.54
Becton Dickinson (BDX) United States $49.818B 12.34
Cardinal Health (CAH) United States $36.754B 19.25
Labcorp (LH) United States $20.653B 16.75
Straumann Holding AG (SAUHY) Switzerland $20.570B 0.00
Cooper (COO) United States $15.991B 20.61
West Pharmaceutical Services (WST) United States $15.121B 31.70
Align Technology (ALGN) United States $13.268B 26.34
Henry Schein (HSIC) United States $8.761B 15.03
Merit Medical Systems (MMSI) United States $5.604B 27.09
DENTSPLY SIRONA (XRAY) United States $3.254B 9.72
CONMED (CNMD) United States $1.785B 13.35
STAAR Surgical (STAA) United States $0.908B 0.00
Pro-Dex (PDEX) United States $0.132B 14.41